Basic Info
  • Grade: pharmaceutical grade

    Factory Location: Shanghai

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Clozotinib is an oral aminopyridine inhibitor that is an inhibitor of receptor tyrosine kinase (ALK) and c-Met/hepatocyte growth factor receptor (HGFR), exhibiting anti-tumor activity. Clozotinib competitively binds to ALK kinase and ALK fusion protein in an ATP competitive manner and inhibits them. In addition, clotozantinib can also inhibit c-Met kinase and disrupt the c-Met signaling pathway. Overall, this medication can inhibit the growth of tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in the development of the nervous system. ALK dysregulation and gene rearrangement are associated with a range of tumors.
Send your message to this supplier
  • From:
  • To:
    Shanghai Hope-chem Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service